ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Molecular Influenza Diagnostic Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-11T9475
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Molecular Influenza Diagnostic Market Insights and Forecast to 2028

Global Molecular Influenza Diagnostic Market Insights and Forecast to 2028

Code: QYRE-Auto-11T9475
Report
January 2022
Pages:113
QYResearch
Description
Table of Content
Tables & Figures
FEATURED COMPANIES
BD
Abbott (Include Alere)
Roche
Siemens AG
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
Biomerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.
Market Analysis and Insights: Global Molecular Influenza Diagnostic Market

The global Molecular Influenza Diagnostic market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Reverse Transcription Polymerase Chain Reaction (RT-PCR) accounting for % of the Molecular Influenza Diagnostic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Molecular Influenza Diagnostic market size is valued at US$ million in 2021, while the North America and Europe Molecular Influenza Diagnostic are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Molecular Influenza Diagnostic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Influenza Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Influenza Diagnostic market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Influenza Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Influenza Diagnostic market.
Global Molecular Influenza Diagnostic Scope and Market Size
Molecular Influenza Diagnostic market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Influenza Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Nucleic Acid Sequence Based Amplification (NASBA) Tests
Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-based Assays (SAMBA)

Segment by Application

Hospitals
POCT
Others

BY COMPANY

BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
FEATURED COMPANIES
BD
Abbott (Include Alere)
Roche
Siemens AG
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
Biomerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Reverse Transcription Polymerase Chain Reaction (RT-PCR)
1.2.3 Nucleic Acid Sequence Based Amplification (NASBA) Tests
1.2.4 Loop-mediated Isothermal Amplification-Based Assays (LAMP)
1.2.5 Simple Amplification-based Assays (SAMBA)
1.3 Market by Application
1.3.1 Global Molecular Influenza Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 POCT
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Influenza Diagnostic Market Perspective (2017-2028)
2.2 Molecular Influenza Diagnostic Growth Trends by Region
2.2.1 Molecular Influenza Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Influenza Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Molecular Influenza Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Molecular Influenza Diagnostic Market Dynamics
2.3.1 Molecular Influenza Diagnostic Industry Trends
2.3.2 Molecular Influenza Diagnostic Market Drivers
2.3.3 Molecular Influenza Diagnostic Market Challenges
2.3.4 Molecular Influenza Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Influenza Diagnostic Players by Revenue
3.1.1 Global Top Molecular Influenza Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Molecular Influenza Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Influenza Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Influenza Diagnostic Revenue
3.4 Global Molecular Influenza Diagnostic Market Concentration Ratio
3.4.1 Global Molecular Influenza Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Influenza Diagnostic Revenue in 2021
3.5 Molecular Influenza Diagnostic Key Players Head office and Area Served
3.6 Key Players Molecular Influenza Diagnostic Product Solution and Service
3.7 Date of Enter into Molecular Influenza Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Influenza Diagnostic Breakdown Data by Type
4.1 Global Molecular Influenza Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2023-2028)
5 Molecular Influenza Diagnostic Breakdown Data by Application
5.1 Global Molecular Influenza Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Influenza Diagnostic Market Size (2017-2028)
6.2 North America Molecular Influenza Diagnostic Market Size by Type
6.2.1 North America Molecular Influenza Diagnostic Market Size by Type (2017-2022)
6.2.2 North America Molecular Influenza Diagnostic Market Size by Type (2023-2028)
6.2.3 North America Molecular Influenza Diagnostic Market Share by Type (2017-2028)
6.3 North America Molecular Influenza Diagnostic Market Size by Application
6.3.1 North America Molecular Influenza Diagnostic Market Size by Application (2017-2022)
6.3.2 North America Molecular Influenza Diagnostic Market Size by Application (2023-2028)
6.3.3 North America Molecular Influenza Diagnostic Market Share by Application (2017-2028)
6.4 North America Molecular Influenza Diagnostic Market Size by Country
6.4.1 North America Molecular Influenza Diagnostic Market Size by Country (2017-2022)
6.4.2 North America Molecular Influenza Diagnostic Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Molecular Influenza Diagnostic Market Size (2017-2028)
7.2 Europe Molecular Influenza Diagnostic Market Size by Type
7.2.1 Europe Molecular Influenza Diagnostic Market Size by Type (2017-2022)
7.2.2 Europe Molecular Influenza Diagnostic Market Size by Type (2023-2028)
7.2.3 Europe Molecular Influenza Diagnostic Market Share by Type (2017-2028)
7.3 Europe Molecular Influenza Diagnostic Market Size by Application
7.3.1 Europe Molecular Influenza Diagnostic Market Size by Application (2017-2022)
7.3.2 Europe Molecular Influenza Diagnostic Market Size by Application (2023-2028)
7.3.3 Europe Molecular Influenza Diagnostic Market Share by Application (2017-2028)
7.4 Europe Molecular Influenza Diagnostic Market Size by Country
7.4.1 Europe Molecular Influenza Diagnostic Market Size by Country (2017-2022)
7.4.2 Europe Molecular Influenza Diagnostic Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Influenza Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type
8.2.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Molecular Influenza Diagnostic Market Share by Type (2017-2028)
8.3 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application
8.3.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Molecular Influenza Diagnostic Market Share by Application (2017-2028)
8.4 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region
8.4.1 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Molecular Influenza Diagnostic Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Influenza Diagnostic Market Size (2017-2028)
9.2 Latin America Molecular Influenza Diagnostic Market Size by Type
9.2.1 Latin America Molecular Influenza Diagnostic Market Size by Type (2017-2022)
9.2.2 Latin America Molecular Influenza Diagnostic Market Size by Type (2023-2028)
9.2.3 Latin America Molecular Influenza Diagnostic Market Share by Type (2017-2028)
9.3 Latin America Molecular Influenza Diagnostic Market Size by Application
9.3.1 Latin America Molecular Influenza Diagnostic Market Size by Application (2017-2022)
9.3.2 Latin America Molecular Influenza Diagnostic Market Size by Application (2023-2028)
9.3.3 Latin America Molecular Influenza Diagnostic Market Share by Application (2017-2028)
9.4 Latin America Molecular Influenza Diagnostic Market Size by Country
9.4.1 Latin America Molecular Influenza Diagnostic Market Size by Country (2017-2022)
9.4.2 Latin America Molecular Influenza Diagnostic Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Influenza Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type
10.2.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Molecular Influenza Diagnostic Market Share by Type (2017-2028)
10.3 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application
10.3.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Molecular Influenza Diagnostic Market Share by Application (2017-2028)
10.4 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country
10.4.1 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Molecular Influenza Diagnostic Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Molecular Influenza Diagnostic Introduction
11.1.4 BD Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.1.5 BD Recent Developments
11.2 Abbott (Include Alere)
11.2.1 Abbott (Include Alere) Company Details
11.2.2 Abbott (Include Alere) Business Overview
11.2.3 Abbott (Include Alere) Molecular Influenza Diagnostic Introduction
11.2.4 Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.2.5 Abbott (Include Alere) Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Molecular Influenza Diagnostic Introduction
11.3.4 Roche Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.3.5 Roche Recent Developments
11.4 SIEMENS
11.4.1 SIEMENS Company Details
11.4.2 SIEMENS Business Overview
11.4.3 SIEMENS Molecular Influenza Diagnostic Introduction
11.4.4 SIEMENS Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.4.5 SIEMENS Recent Developments
11.5 Analytik Jena
11.5.1 Analytik Jena Company Details
11.5.2 Analytik Jena Business Overview
11.5.3 Analytik Jena Molecular Influenza Diagnostic Introduction
11.5.4 Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.5.5 Analytik Jena Recent Developments
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Molecular Influenza Diagnostic Introduction
11.6.4 Quidel Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.6.5 Quidel Recent Developments
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Molecular Influenza Diagnostic Introduction
11.7.4 Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.7.5 Thermo Fisher Recent Developments
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Molecular Influenza Diagnostic Introduction
11.8.4 Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.8.5 Meridian Bioscience Recent Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Details
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Molecular Influenza Diagnostic Introduction
11.9.4 BioMerieux Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.9.5 BioMerieux Recent Developments
11.10 Sekisui Diagnostics
11.10.1 Sekisui Diagnostics Company Details
11.10.2 Sekisui Diagnostics Business Overview
11.10.3 Sekisui Diagnostics Molecular Influenza Diagnostic Introduction
11.10.4 Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.10.5 Sekisui Diagnostics Recent Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Details
11.11.2 Response Biomedical Business Overview
11.11.3 Response Biomedical Molecular Influenza Diagnostic Introduction
11.11.4 Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.11.5 Response Biomedical Recent Developments
11.12 SA Scientific
11.12.1 SA Scientific Company Details
11.12.2 SA Scientific Business Overview
11.12.3 SA Scientific Molecular Influenza Diagnostic Introduction
11.12.4 SA Scientific Revenue in Molecular Influenza Diagnostic Business (2017-2022)
11.12.5 SA Scientific Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
BD
Abbott (Include Alere)
Roche
Siemens AG
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
Biomerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
List of Tables
    Table 1. Global Molecular Influenza Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    Table 3. Key Players of Nucleic Acid Sequence Based Amplification (NASBA) Tests
    Table 4. Key Players of Loop-mediated Isothermal Amplification-Based Assays (LAMP)
    Table 5. Key Players of Simple Amplification-based Assays (SAMBA)
    Table 6. Global Molecular Influenza Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Molecular Influenza Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Molecular Influenza Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Molecular Influenza Diagnostic Market Share by Region (2017-2022)
    Table 10. Global Molecular Influenza Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Molecular Influenza Diagnostic Market Share by Region (2023-2028)
    Table 12. Molecular Influenza Diagnostic Market Trends
    Table 13. Molecular Influenza Diagnostic Market Drivers
    Table 14. Molecular Influenza Diagnostic Market Challenges
    Table 15. Molecular Influenza Diagnostic Market Restraints
    Table 16. Global Molecular Influenza Diagnostic Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Molecular Influenza Diagnostic Revenue Share by Players (2017-2022)
    Table 18. Global Top Molecular Influenza Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Influenza Diagnostic as of 2021)
    Table 19. Ranking of Global Top Molecular Influenza Diagnostic Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Molecular Influenza Diagnostic Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Molecular Influenza Diagnostic Product Solution and Service
    Table 23. Date of Enter into Molecular Influenza Diagnostic Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2017-2022)
    Table 27. Global Molecular Influenza Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Molecular Influenza Diagnostic Revenue Market Share by Type (2023-2028)
    Table 29. Global Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Molecular Influenza Diagnostic Revenue Share by Application (2017-2022)
    Table 31. Global Molecular Influenza Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Molecular Influenza Diagnostic Revenue Share by Application (2023-2028)
    Table 33. North America Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Molecular Influenza Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Molecular Influenza Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Molecular Influenza Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Molecular Influenza Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Molecular Influenza Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Molecular Influenza Diagnostic Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Molecular Influenza Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Molecular Influenza Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Molecular Influenza Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Molecular Influenza Diagnostic Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Molecular Influenza Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Molecular Influenza Diagnostic Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Molecular Influenza Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Molecular Influenza Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 63. BD Company Details
    Table 64. BD Business Overview
    Table 65. BD Molecular Influenza Diagnostic Product
    Table 66. BD Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 67. BD Recent Developments
    Table 68. Abbott (Include Alere) Company Details
    Table 69. Abbott (Include Alere) Business Overview
    Table 70. Abbott (Include Alere) Molecular Influenza Diagnostic Product
    Table 71. Abbott (Include Alere) Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 72. Abbott (Include Alere) Recent Developments
    Table 73. Roche Company Details
    Table 74. Roche Business Overview
    Table 75. Roche Molecular Influenza Diagnostic Product
    Table 76. Roche Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 77. Roche Recent Developments
    Table 78. SIEMENS Company Details
    Table 79. SIEMENS Business Overview
    Table 80. SIEMENS Molecular Influenza Diagnostic Product
    Table 81. SIEMENS Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 82. SIEMENS Recent Developments
    Table 83. Analytik Jena Company Details
    Table 84. Analytik Jena Business Overview
    Table 85. Analytik Jena Molecular Influenza Diagnostic Product
    Table 86. Analytik Jena Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 87. Analytik Jena Recent Developments
    Table 88. Quidel Company Details
    Table 89. Quidel Business Overview
    Table 90. Quidel Molecular Influenza Diagnostic Product
    Table 91. Quidel Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 92. Quidel Recent Developments
    Table 93. Thermo Fisher Company Details
    Table 94. Thermo Fisher Business Overview
    Table 95. Thermo Fisher Molecular Influenza Diagnostic Product
    Table 96. Thermo Fisher Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 97. Thermo Fisher Recent Developments
    Table 98. Meridian Bioscience Company Details
    Table 99. Meridian Bioscience Business Overview
    Table 100. Meridian Bioscience Molecular Influenza Diagnostic Product
    Table 101. Meridian Bioscience Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 102. Meridian Bioscience Recent Developments
    Table 103. BioMerieux Company Details
    Table 104. BioMerieux Business Overview
    Table 105. BioMerieux Molecular Influenza Diagnostic Product
    Table 106. BioMerieux Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 107. BioMerieux Recent Developments
    Table 108. Sekisui Diagnostics Company Details
    Table 109. Sekisui Diagnostics Business Overview
    Table 110. Sekisui Diagnostics Molecular Influenza Diagnostic Product
    Table 111. Sekisui Diagnostics Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 112. Sekisui Diagnostics Recent Developments
    Table 113. Response Biomedical Company Details
    Table 114. Response Biomedical Business Overview
    Table 115. Response Biomedical Molecular Influenza Diagnostic Product
    Table 116. Response Biomedical Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 117. Response Biomedical Recent Developments
    Table 118. SA Scientific Company Details
    Table 119. SA Scientific Business Overview
    Table 120. SA Scientific Molecular Influenza Diagnostic Product
    Table 121. SA Scientific Revenue in Molecular Influenza Diagnostic Business (2017-2022) & (US$ Million)
    Table 122. SA Scientific Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Molecular Influenza Diagnostic Market Share by Type: 2021 VS 2028
    Figure 2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) Features
    Figure 3. Nucleic Acid Sequence Based Amplification (NASBA) Tests Features
    Figure 4. Loop-mediated Isothermal Amplification-Based Assays (LAMP) Features
    Figure 5. Simple Amplification-based Assays (SAMBA) Features
    Figure 6. Global Molecular Influenza Diagnostic Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. POCT Case Studies
    Figure 9. Others Case Studies
    Figure 10. Molecular Influenza Diagnostic Report Years Considered
    Figure 11. Global Molecular Influenza Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Molecular Influenza Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Molecular Influenza Diagnostic Market Share by Region: 2021 VS 2028
    Figure 14. Global Molecular Influenza Diagnostic Market Share by Players in 2021
    Figure 15. Global Top Molecular Influenza Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Influenza Diagnostic as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Molecular Influenza Diagnostic Revenue in 2021
    Figure 17. North America Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 19. North America Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 20. North America Molecular Influenza Diagnostic Market Size Share by Country (2017-2028)
    Figure 21. United States Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Molecular Influenza Diagnostic Market Size Share by Country (2017-2028)
    Figure 27. Germany Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Molecular Influenza Diagnostic Market Size Share by Region (2017-2028)
    Figure 37. China Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Molecular Influenza Diagnostic Market Size Share by Country (2017-2028)
    Figure 47. Mexico Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Molecular Influenza Diagnostic Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Molecular Influenza Diagnostic Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Molecular Influenza Diagnostic Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Molecular Influenza Diagnostic Market Size Share by Country (2017-2028)
    Figure 53. Turkey Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Molecular Influenza Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. BD Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 57. Abbott (Include Alere) Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 59. SIEMENS Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 60. Analytik Jena Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 61. Quidel Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 62. Thermo Fisher Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 63. Meridian Bioscience Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 64. BioMerieux Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 65. Sekisui Diagnostics Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 66. Response Biomedical Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 67. SA Scientific Revenue Growth Rate in Molecular Influenza Diagnostic Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT
HAVE A QUERY?
INQUIRE ABOUT REPORT EMAIL US
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICIES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions